136 related articles for article (PubMed ID: 25150234)
1. A 27-year-old woman presenting with refractory hypoxaemic respiratory failure, haemoptysis and thyrotoxicosis: a rare manifestation of propylthiouracil therapy.
Ortiz-Diaz EO
BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25150234
[TBL] [Abstract][Full Text] [Related]
2. Diffuse alveolar hemorrhage associated with antineutrophil cytoplasmic antibody levels in a pregnant woman taking propylthiouracil.
Kang AY; Baek YH; Sohn YJ; Lee SK; Son CH; Kim K; Yang DK
Korean J Intern Med; 2006 Dec; 21(4):240-3. PubMed ID: 17249506
[TBL] [Abstract][Full Text] [Related]
3. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
5. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
6. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
11. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
[TBL] [Abstract][Full Text] [Related]
13. [Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].
Pietszkowski NC; Carvalho GA; Souza HN; Werka CR; Borazo LA; Graf H; Carvalho Md
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):136-41. PubMed ID: 17435868
[TBL] [Abstract][Full Text] [Related]
14. Propylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA).
Nakamori Y; Tominaga T; Inoue Y; Shinohara K
Intern Med; 2003 Jun; 42(6):529-33. PubMed ID: 12857055
[TBL] [Abstract][Full Text] [Related]
15. [Myeloperoxidase-antineutrophil cytoplasmic antibody positive alveolar hemorrhage during propylthiouracil therapy for hyperthyroidism].
Makiyama Y; Ito M; Akiyama F; Sega H; Togashi K; Hasegawa T; Suzuki E; Arakawa M; Gejyo F
Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):201-5. PubMed ID: 10846402
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
17. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
18. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody.
Ohtsuka M; Yamashita Y; Doi M; Hasegawa S
Eur Respir J; 1997 Jun; 10(6):1405-7. PubMed ID: 9192950
[TBL] [Abstract][Full Text] [Related]
19. Propylthiouracil-induced antineutrophil cytoplasm antibody-positive anaphylactoid purpura-like vasculitis--a case report.
Wang LH; Tsai MJ; Tsai WY; Lee JS; Chiang BL
J Formos Med Assoc; 2000 Aug; 99(8):642-5. PubMed ID: 10969508
[TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody.
Criado PR; Grizzo Peres Martins AC; Gaviolli CF; Alavi A
Int J Low Extrem Wounds; 2015 Jun; 14(2):187-91. PubMed ID: 25256279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
